We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




First-of-Its-Kind Minimally Invasive Surgery Platform Combines Magnets and Machines

By HospiMedica International staff writers
Posted on 23 Aug 2023
Print article
Image: The Levita MARS System has received U.S. FDA clearance (Photo courtesy of Levita Magnetics)
Image: The Levita MARS System has received U.S. FDA clearance (Photo courtesy of Levita Magnetics)

Magnetic surgery represents a breakthrough aimed at enhancing the advantages of minimally invasive procedures, with prior research clearly demonstrating its clinical merits. Similarly, robotic-assisted surgery increases surgeon control over instruments, leading to reduced reliance on assistants. Now, a first-of-its-kind minimally invasive surgery platform combines magnets and machines to bring multiple benefits to patients, surgeons, and surgery centers.

The Levita MARS system from Levita Magnetics (Silicon Valley, CA, USA) is a pioneering minimally invasive surgical solution specifically designed for high-volume abdominal surgeries. MARS capitalizes on the powerful combination of magnets and machines to reduce incisions and grant surgeons complete control during laparoscopic procedures. This remarkable capability is contained in a compact footprint tailored to integrate into existing operating rooms. The MARS system builds on the successful Levita Magnetic Surgical System, offering similar patient advantages offered by magnetic surgery. Simultaneously, it empowers surgeons with increased instrument control and provides hospitals and ambulatory surgery centers (ASCs) an effective means of adopting this innovative technology.

With MARS, patients experience less invasive surgery marked by fewer incisions, translating to a reduction in discomfort, speedier recuperation, and less scarring. Surgeons reap the benefits of a surgical system that offers them complete control over both the laparoscopic view - thereby eliminating the need for an additional assistant - as well as over the Magnetic Surgical System. This enables the retraction of large tissues and organs like the liver, gallbladder, prostate, and colon. Notably, medical facilities can enhance operational efficiency, optimize utilization of operating room personnel, and offer a differentiated patient experience. Levita has received clearance from the U.S. Food and Drug Administration (FDA) for its MARS platform.

"Today marks a significant milestone in Levita's mission to provide more patients access to state-of-the-art surgical technology. MARS is poised to revolutionize surgical options for a broad range of patients," said Dr. Alberto Rodriguez-Navarro, surgeon, founder, and CEO of Levita Magnetics. "With this FDA clearance, we eagerly anticipate making a substantial impact across the value chain."

"MARS by Levita has the potential to reshape the surgical industry and forever change medical innovation. Our pioneering MARS platform gives patients and surgeons a transformative tool that will usher in a fundamental shift in surgery for years to come," said Levita Chairperson Maria Sainz. "Levita's system can aid in surgeon proficiency and efficiency, and can reduce the need for assistive personnel, signaling a major achievement not only for Levita but for surgical care."

Related Links:
Levita Magnetics 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Diagnostic Ultrasound System
MS1700C
New
Ultrasonic Cleaner
Cole-Parmer Ultrasonic Cleaner with Digital Timer

Print article

Channels

Critical Care

view channel
Image: Changes in immune cells can predict patient recovery following out-of-hospital cardiac arrest (Photo courtesy of Adobe Stock)

Activating T Cells Could Improve Neurological Outcomes After Cardiac Arrest

Despite advancements in cardiopulmonary resuscitation (CPR) and improved hospital access, survival rates after out-of-hospital cardiac arrest (OHCA) remain low, with only about 10% of patients surviving.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.